NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
For most patients, the moment a doctor utters the words “you have cancer” is not simply...
In November 2025, the US Food and Drug Administration (FDA) approved epcoritamab with rituximab and lenalidomide...
In 2001, Ireland became one of the first countries in the world to publish a national...
Combining the bispecific monoclonal antibody teclistamab with the CD38 monoclonal antibody, daratumumab, may increase three-year...
To celebrate World Cancer Day held on 4 February 2026, the European Commission, in collaboration with...
Ciltacabtagene autoleucel (cilta-cel) has demonstrated unprecedented response rates and progression-free survival (PFS)...
In October, St James’s Hospital in Dublin announced the appointment of Prof Michael Eamon Kelly as...
The conference also heard from Ms Brid O’Riordan, Cancer Survivorship Clinical Nurse Specialist, who delivered a...
Cancer is one of the leading causes of death in Ireland, with approximately 10,000 deaths recorded...
Dr Iseult Browne, Royal Marsden Hospital, London, UK, delivered a presentation titled ‘Integrating circulating tumour DNA...
The RCPI Faculty of Paediatrics Autumn Conference in October highlighted decades of work dedicated to raising...
Speaking at Gathering Around Cancer 2025, Prof Seamus O’Reilly, Cork University Hospital, provided an update on...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT